ANTHEM BIOSCIENCES
|
The Current P/S Ratio of ANTHEM BIOSCIENCES is 25.85.
| Share Price | ₹918.4 | Sep 21,2026 |
| Market Cap | ₹51,751.8 Cr | |
| Sales-TTM | ₹2,002.3 Cr | TTM-Consolidated Results |
| Price/Sales | 25.85x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ANTHEM BIOSCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹51,751.8 Cr] as on Sep 21,2026
(/) Sales [ ₹2,002.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 25.85x ]
Thus, for ANTHEM BIOSCIENCES , the investors are currently willing to pay '25.85 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ANTHEM BIOSCIENCES !
The chart below summarizes the trend in P/S Ratio of ANTHEM BIOSCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of ANTHEM BIOSCIENCES
PS Ratio Performance Analysis for ANTHEM BIOSCIENCES
- ANTHEM BIOSCIENCES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 3.47x.
- ANTHEM BIOSCIENCES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ANTHEM BIOSCIENCES 's p/e ratio peaked in Mar2026 at 17.35x.
- ANTHEM BIOSCIENCES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does ANTHEM BIOSCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ANTHEM BIOSCIENCES | 2,002.3 | 25.85 | 51,751.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.48 | 448,196.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.30 | 250,390.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.02 | 188,967.0 |
| CIPLA LTD | 28,324.4 | 3.95 | 111,888.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.02 | 100,329.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.81 | 100,364.0 |
| LUPIN LTD | 29,966.6 | 3.23 | 96,940.4 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.05 | 115,860.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.83 | 98,803.9 |
| LAURUS LABS LTD | 7,269.6 | 15.00 | 109,035.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ANTHEM BIOSCIENCES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.83x |
| Max industry PS | 25.85x |
| Median industry PS | 6.81x |
| Average industry PS | 9.69x |
You may also like the below Video Courses